External broker reports(aggregated public sources), HDFC Securities

HDFC Securities

External broker reports(aggregated public sources)

HDFC securities is the best online trading platform for stocks, IPOs, mutual fund in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Entero Healthcare Solutions / Equity Bottom-Up

<ul><li>We recently interacted with Entero's senior management</li><li>The key highlights were: (1) In FY25, the company expects 35-40% revenue growth, with ~15-16% organic growth (outperforming IPM by 1.5x) and the remaining growth coming from acquisitions (targets ~INR 10 bn annualised sales from in FY25)</li><li>Over the mid-to-long term, the company aims to outperform IPM by 2x</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

We recently interacted with Entero's senior managementThe key highlights were: (1) In FY25, the company expects 35-40% revenue growth, with ~15-16% organic growth (outperforming IPM by 1.5x) and the remaining growth coming from acquisitions (targets ~INR 10 bn annualised sales from in FY25)Over the mid-to-long term, the company aims to outperform IPM by 2xContent is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Entero Healthcare Solutions: Well-Placed to Consolidate Pharma Distribution. NOT RATED

India

Entero Healthcare Solutions Limited is a large-scale distributor of healthcare products in India, providing an integrated platform for demand generation and fulfillment. The company distributes pharmaceuticals, medical devices, surgical consumables, nutraceuticals, and over-the-counter products to retail pharmacies and hospitals. Entero Healthcare Solutions was founded in 2018 and is headquartered in Mumbai, India.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Entero Healthcare Solutions (ENTERO IN)

Entero Healthcare Solutions: Well-Placed to Consolidate Pharma Distribution. NOT RATED

The key highlights were: (1) In FY25, the company expects 35-40% revenue growth, with ~15-16% organic growth (outperforming IPM by 1.5x) and the...

HDFC Securities

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)